Zenotech Laboratories Limited specializes in Pharmaceuticals within the Healthcare sector.
Zenotech Laboratories Limited, with Security Code 532039, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
|---|---|---|---|---|---|---|---|---|---|
| 2024-01-01 | 2024-03-31 | 80.90 | 6.60 | 94.34 | 0.11 | -36.47 | 13.44 | -17.33 | 13.73 |
| 2023-10-01 | 2023-12-31 | 109.42 | 33.61 | 112.27 | 0.55 | -33.42 | 2.85 | -17.44 | 38.04 |
| 2023-07-01 | 2023-09-30 | 105.10 | 28.31 | 117.20 | 0.46 | -37.98 | 12.11 | -18.07 | 38.98 |
| 2023-04-01 | 2023-06-30 | 82.38 | 14.45 | 94.56 | 0.24 | -33.60 | 12.19 | -18.01 | 20.67 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 26% |
| 3 Years: | 22% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 36% |
| 3 Years: | 106% |
| TTM: | -28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 31% |
| 3 Years: | 15% |
| 1 Year: | 13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -20% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 31% |
| 3 Years: | 15% |
| 1 Year: | 13% |
Zenotech Laboratories, a leading provider of diagnostic services, has announced a strategic collaboration with Apollo Hospitals to enhance the quality and accessibility of healthcare services for patients.
Zenotech Laboratories is pleased to announce the expansion of its operations in South India with the opening of a new state-of-the-art laboratory in Hyderabad.
Zenotech Laboratories has been awarded ISO 15189 accreditation for its laboratory services, demonstrating its commitment to providing high-quality and reliable diagnostic testing.
